Cargando…

Corticosteroid and Biologic Use Not Associated With Adverse Outcomes for Inflammatory Bowel Disease Patients Hospitalized With COVID-19

BACKGROUND: To date, studies investigating the inflammatory bowel disease (IBD) patient experience with coronavirus disease 2019 (COVID-19) have consistently reported that the observed rate of COVID-19 within this population is similar to the general population. Limited research has suggested that c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sultan, Keith, Durbin, Laura, Bhardwaj, Richa, Mackey, James, Becher, Noah, Abureesh, Mohammad, Lakhani, Komal, Mone, Anjali, Abergel, Jeffrey, Trindade, Arvind, Korelitz, Burton I., Swaminath, Arun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734496/ https://www.ncbi.nlm.nih.gov/pubmed/35059066 http://dx.doi.org/10.14740/gr1447

Ejemplares similares

Review of inflammatory bowel disease and COVID-19
por: Sultan, Keith, et al.
Publicado: (2020)

Fatigue in Inflammatory Bowel Diseases: Etiologies and Management
por: Nocerino, Angelica, et al.
Publicado: (2019)

A Literature Review of Ozanimod Therapy in Inflammatory Bowel Disease: From Concept to Practical Application
por: Becher, Noah, et al.
Publicado: (2022)

Ideal Vial Size for Infliximab in the Treatment of Inflammatory Bowel Disease: An Analysis of Pharmaceutical Waste and Physician Opinions
por: Schachne, Jonathan M, et al.
Publicado: (2021)

Cannabis Use and Its Association With Thirty- and Ninety-Day Hospital Readmissions for Patients Admitted for an Inflammatory Bowel Disease Exacerbation
por: Oseni, Ellen A., et al.
Publicado: (2023)

The Course of SARS-COV2 Infection Was Not Severe in a Crohn’s Patient Who Administered Maintenance Anti-TNF Therapy Overlapping the Early Pre-Symptomatic Period of Infection
por: Okeke, Francis, et al.
Publicado: (2020)

Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective
por: Axelrad, Jordan E, et al.
Publicado: (2016)

COVID-19 Vaccination and Inflammatory Bowel Disease: Desired Antibody Responses, Future Directions, and a Note of Caution
por: Levine, Irving, et al.
Publicado: (2022)

Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
por: Fleisher, Mark, et al.
Publicado: (2018)

Presentation and outcomes among inflammatory bowel disease patients with concurrent pneumatosis intestinalis: a case series and systematic review
por: Gao, Youran, et al.
Publicado: (2020)

Clostridiodes difficile Treatment Guided by Polymerase Chain Reaction Stool Testing Does not Alter Outcomes for Patients With Inflammatory Bowel Disease
por: Chandrabos, Ceena, et al.
Publicado: (2021)

Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians
por: Buckley, Megan C., et al.
Publicado: (2021)

The Changing Prognosis of Ulcerative Colitis and Crohn Disease by Decades
por: Korelitz, Burton I, et al.
Publicado: (2021)

Safety of biologics in inflammatory bowel disease patients with COVID-19
por: Weissman, Simcha, et al.
Publicado: (2021)

The impact of corticosteroid use on inpatients with inflammatory bowel disease and positive polymerase chain reaction for Clostridium difficile
por: Lim, Huei-Wen, et al.
Publicado: (2019)

Fr501 BIOLOGICS AND COVID-19 OUTCOMES IN INFLAMMATORY BOWEL DISEASE PATIENTS
por: Weissman, Simcha, et al.
Publicado: (2021)

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
por: Brenner, Erica J., et al.
Publicado: (2020)

Adverse birth outcomes and early-life infections after in utero exposure to corticosteroids for inflammatory bowel disease: a Danish nationwide cohort study
por: Jølving, Line Riis, et al.
Publicado: (2023)

Misuse of topical corticosteroids: A clinical study of adverse effects
por: Dey, Vivek Kumar
Publicado: (2014)

Adverse events related to low dose corticosteroids in autoimmune hepatitis
por: van den Brand, Floris F., et al.
Publicado: (2019)

Association of Oral Corticosteroid Bursts With Severe Adverse Events in Children
por: Yao, Tsung-Chieh, et al.
Publicado: (2021)

Ticagrelor: An investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome
por: Abergel, Eitan, et al.
Publicado: (2010)

Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort
por: Waljee, Akbar K., et al.
Publicado: (2016)

CME Exam 1: Corticosteroids, But Not TNF Antagonists, Are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
Publicado: (2020)

Corticosteroid, a double-edged sword in inflammatory bowel disease management: possibility of reducing corticosteroid use through physician education
por: Kim, Seulji, et al.
Publicado: (2022)

Adverse effects of extra-articular corticosteroid injections: a systematic review
por: Brinks, Aaltien, et al.
Publicado: (2010)

Topical Corticosteroids Abuse: A Clinical Study of Cutaneous Adverse Effects
por: Meena, Soniya, et al.
Publicado: (2017)

Psychiatric Adverse Effects of treatement with Corticosteroids: A Tunisian case report
por: Boussaid, N., et al.
Publicado: (2023)

Current Practice and Perception of Screening for Medication Adherence in Inflammatory Bowel Disease
por: Trindade, Arvind J., et al.
Publicado: (2011)

Co-existing inflammatory bowel disease and Barrett’s esophagus is associated with esophageal dysplasia: a propensity score-matched cohort
por: Fasullo, Matthew, et al.
Publicado: (2021)

Correction: Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort
por: Waljee, Akbar K., et al.
Publicado: (2018)

Replicating prediction algorithms for hospitalization and corticosteroid use in patients with inflammatory bowel disease
por: Gan, Ryan W., et al.
Publicado: (2021)

Severe Adverse Effects Associated With Corticosteroid Treatment in Patients With IgA Nephropathy
por: Cai, Qingqing, et al.
Publicado: (2017)

Adverse Effects of Long-Term Oral Corticosteroids in the Department of Dermatology, Antananarivo, Madagascar
por: Sendrasoa, Fandresena Arilala, et al.
Publicado: (2021)

Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD
por: Miravitlles, Marc, et al.
Publicado: (2021)

Association between antenatal corticosteroid treatment and severe adverse events in pregnant women
por: Tsai, Hui-Ju, et al.
Publicado: (2023)

Local adverse effects associated with the use of inhaled corticosteroids in patients with moderate or severe asthma
por: Pinto, Charleston Ribeiro, et al.
Publicado: (2013)

Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study
por: Price, David B, et al.
Publicado: (2018)

The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study
por: Auyeung, Tung Wai, et al.
Publicado: (2005)

Systemic adverse effects from inhaled corticosteroid use in asthma: a systematic review
por: Patel, Roshni, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rv2j2fa24geou18gdf58h03sis